Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Source: 
CP Wire
snippet: 

This week, stories from PTC Therapeutics, Novartis, and Novo Nordisk topped our most-read news links, as well as a piece about potential buyers for Baxter’s biopharma solutions business.